Sergei Lobov

585 total citations
19 papers, 457 citations indexed

About

Sergei Lobov is a scholar working on Cancer Research, Molecular Biology and Hematology. According to data from OpenAlex, Sergei Lobov has authored 19 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Sergei Lobov's work include Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Peptidase Inhibition and Analysis (3 papers). Sergei Lobov is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Peptidase Inhibition and Analysis (3 papers). Sergei Lobov collaborates with scholars based in Australia, Sweden and Canada. Sergei Lobov's co-authors include Marie Ranson, David R. Croucher, Darren N. Saunders, Liudmila N. Novikova, Lev N. Novikov, Mikael Wiberg, Tor Ny, Blake J. Cochran, Małgorzata Wilczyńska and Lennart B.‐Å. Johansson and has published in prestigious journals such as Journal of Biological Chemistry, Nature reviews. Cancer and Biomaterials.

In The Last Decade

Sergei Lobov

17 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergei Lobov Australia 12 172 158 74 70 63 19 457
Suresh Jivan Gadher Czechia 15 381 2.2× 113 0.7× 60 0.8× 99 1.4× 46 0.7× 37 856
Xi Jin China 12 224 1.3× 54 0.3× 81 1.1× 27 0.4× 52 0.8× 34 499
Jerry C. Cheng United States 14 387 2.3× 108 0.7× 39 0.5× 136 1.9× 109 1.7× 28 707
Mario Vallon Germany 12 308 1.8× 55 0.3× 92 1.2× 60 0.9× 28 0.4× 17 549
Sylvia A. Rayner United States 20 433 2.5× 90 0.6× 46 0.6× 182 2.6× 28 0.4× 35 1.2k
Viji Shridhar United States 10 287 1.7× 68 0.4× 47 0.6× 60 0.9× 16 0.3× 10 536
Eitan Wong United States 14 262 1.5× 55 0.3× 51 0.7× 140 2.0× 26 0.4× 15 578
Núria Colomé Spain 16 421 2.4× 120 0.8× 57 0.8× 122 1.7× 30 0.5× 25 768
Iordanka A. Ivanova Canada 14 262 1.5× 78 0.5× 16 0.2× 128 1.8× 35 0.6× 21 497
Maryam Zarghooni Canada 11 461 2.7× 190 1.2× 14 0.2× 110 1.6× 63 1.0× 13 823

Countries citing papers authored by Sergei Lobov

Since Specialization
Citations

This map shows the geographic impact of Sergei Lobov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Lobov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Lobov more than expected).

Fields of papers citing papers by Sergei Lobov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Lobov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Lobov. The network helps show where Sergei Lobov may publish in the future.

Co-authorship network of co-authors of Sergei Lobov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Lobov. A scholar is included among the top collaborators of Sergei Lobov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Lobov. Sergei Lobov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Freeman, Craig, et al.. (2013). The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs. Biomaterials. 34(22). 5670–5676. 37 indexed citations
3.
Lobov, Sergei, et al.. (2012). Cationised radiolabelled nanoparticles for perfusion imaging of the lungs. Biomaterials. 34(6). 1732–1738. 11 indexed citations
4.
Cochran, Blake J., David R. Croucher, Sergei Lobov, Darren N. Saunders, & Marie Ranson. (2011). Dependence on Endocytic Receptor Binding via a Minimal Binding Motif Underlies the Differential Prognostic Profiles of SerpinE1 and SerpinB2 in Cancer. Journal of Biological Chemistry. 286(27). 24467–24475. 13 indexed citations
6.
Cochran, Blake J., et al.. (2011). Forty Years Later and the Role of Plasminogen Activator Inhibitor Type 2/SERPINB2 Is Still an Enigma. Seminars in Thrombosis and Hemostasis. 37(4). 395–407. 31 indexed citations
7.
Novikova, Liudmila N., Sergei Lobov, Mikael Wiberg, & Lev N. Novikov. (2010). Efficacy of olfactory ensheathing cells to support regeneration after spinal cord injury is influenced by method of culture preparation. Experimental Neurology. 229(1). 132–142. 54 indexed citations
8.
Pettersson, Jonas, Sergei Lobov, & Liudmila N. Novikova. (2009). Labeling of olfactory ensheathing glial cells with fluorescent tracers for neurotransplantation. Brain Research Bulletin. 81(1). 125–132. 11 indexed citations
9.
Cochran, Blake J., et al.. (2009). The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity. BMC Biotechnology. 9(1). 43–43. 18 indexed citations
10.
Bommer, Ulrich‐Axel, Amandine Perrin, Philip R. Dash, et al.. (2009). Roles of the translationally controlled tumour protein (TCTP) and the double-stranded RNA-dependent protein kinase, PKR, in cellular stress responses. Oncogene. 29(5). 763–773. 39 indexed citations
11.
Croucher, David R., Darren N. Saunders, Sergei Lobov, & Marie Ranson. (2008). Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nature reviews. Cancer. 8(7). 535–545. 150 indexed citations
12.
Lobov, Sergei, David R. Croucher, Darren N. Saunders, & Marie Ranson. (2008). Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro. Thrombosis and Haemostasis. 100(8). 319–329. 15 indexed citations
13.
Lobov, Sergei, David R. Croucher, & Marie Ranson. (2006). ID: 138 Assessment of known/potential binding sites in the PAI-2 CD-loop for interaction with annexin II and endocytosis receptors. Journal of Thrombosis and Haemostasis. 4(s1). 198–198.
14.
Lobov, Sergei, Małgorzata Wilczyńska, Fredrik Bergström, Lennart B.‐Å. Johansson, & Tor Ny. (2004). Structural Bases of the Redox-dependent Conformational Switch in the Serpin PAI-2. Journal of Molecular Biology. 344(5). 1359–1368. 21 indexed citations
15.
Isaksson, M., et al.. (2004). Partial donor–donor energy migration (PDDEM): A novel fluorescence method for internal protein distance measurements. Physical Chemistry Chemical Physics. 6(11). 3001–3008. 9 indexed citations
16.
Lobov, Sergei, et al.. (2004). Plasminogen activator inhibitor type 2 is a unique serpin with two mobile functional loops..
17.
Kotova, Irina, Anna Lena Chabes, Sergei Lobov, Lars Thelander, & Stefan Björklund. (2003). Sequences downstream of the transcription initiation site are important for proper initiation and regulation of mouse ribonucleotide reductase R2 gene transcription. European Journal of Biochemistry. 270(8). 1791–1801. 8 indexed citations
18.
Kalinin, Stanislav, et al.. (2003). An Environmental-Sensitive BODIPY®-Derivative with Bioapplication: Spectral and Photophysical Properties. Journal of Fluorescence. 13(5). 379–384. 10 indexed citations
19.
Wilczyńska, Małgorzata, Sergei Lobov, & Tor Ny. (2003). The spontaneous polymerization of plasminogen activator inhibitor type‐2 and Z‐antitrypsin are due to different molecular aberrations. FEBS Letters. 537(1-3). 11–16. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026